Article
A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.
Ethnicity & disease - 1 Jan 2020
Clement Yuri, Singh Shamjeet, Motilal Shastri, Maharaj Rohan, Nunez-Smith Marcella
Abstract excerpt
Background: Metformin is the drug of first choice in people newly diagnosed with type 2 diabetes. Most patients respond to metformin monotherapy, but many others remain uncontrolled even at maximal doses. Although non-adherence is a major contributor to non-response, genetic polymorphisms of organic cation transporters play an important role in clinical response. We hypothesize that genetic variants are partly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
